The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes

Haematologica. 2003 Jan;88(1):109-10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / analysis
  • Cyclin E / analysis*
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / metabolism*
  • Myelodysplastic Syndromes / mortality
  • Prevalence
  • Prognosis
  • Proliferating Cell Nuclear Antigen / analysis*
  • Survival Rate

Substances

  • Biomarkers
  • Cyclin E
  • Proliferating Cell Nuclear Antigen
  • p27 antigen